glp-1 vs gip-1 The dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist tirzepatide: a novel cardiometabolic therapeutic prospect | Cardiovascular Diabetology GLP-1 and GIP: Magic bullet

Common Causes of Acne Excess Oil Production : Overproduction of sebum clogs pores with oil and dead skin cells

10.3390/metabo14090483 Metabolites

Some patients report improved skin quality after starting hormone replacement therapy, although treatment should always be individualized medically

Significant vomiting or diarrhea can lead to dehydration and acute kidney injury

doi: 10.3389/fendo.2022.882998 Received 24 February 2022 Accepted 21 September 2022 Published 10 October 2022 Volume 13 - 2022 Edited by ke Sjholm, Gvle Hospital, Sweden Reviewed by Zhanna Belaya, Endocrinology Research Center, Russia

Protective effects of glucagon-like peptide-1 receptor agonists on endothelial dysfunction in diabetes mellitus: a review of preclinical and clinical studies